Novogene(HK) Limited

Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 76 NGS-related patents, as well as more than 26,520 SCI articles with a total impact factor of nearly 176,950, including publications in first tiers journals such as Cell, Nature and Science.
As the largest NGS service provider, Novogene has branches in US, UK, Germany, Singapore, Netherlands, China and Japan. Novogene was founded in 2011 and has been growing rapidly over the past few years, and has genomic sequencing labs in the US, the UK , Germany , China, Singapore, and Japan.